Publisher
Springer Science and Business Media LLC
Reference88 articles.
1. Yoshida K, Zhao P, Zhang L, Abernethy DR, Rekic D, Reynolds KS, et al. In vitro-in vivo extrapolation of metabolism- and transporter-mediated drug-drug interactions: overview of basic prediction methods. J Pharm Sci. 2017;106(9):2209–13.
2. US Food and Drug Administration. In vitro drug interaction studies: cytochrome P450 enzyme- and transporter-mediated drug interactions. Guidance for industry. January 2020:1-46. Available from: https://www.fda.gov/media/134582/download. Accessed 25 May 2024.
3. Saad AAA, Zhang F, Mohammed EAH, Wu X. Clinical aspects of drug-drug interaction and drug nephrotoxicity at renal organic cation transporters 2 (OCT2) and multidrug and toxin exclusion 1, and 2-K (MATE1/MATE2-K). Biol Pharm Bull. 2022;45(4):382–93.
4. Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, International Transporter Consortium, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215–36.
5. Zhang L, Liu Q, Huang SM, Lionberger R. Transporters in regulatory science: notable contributions from Dr. Giacomini in the past two decades. Drug Metab Dispos. 2022;50(9):1211–7.